Details for New Drug Application (NDA): 074817
✉ Email this page to a colleague
NDA 074817 describes INVAGESIC FORTE, which is a drug marketed by Sandoz and is included in one NDA. Additional details are available on the INVAGESIC FORTE profile page.
The generic ingredient in INVAGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
The generic ingredient in INVAGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for 074817
| Tradename: | INVAGESIC FORTE |
| Applicant: | Sandoz |
| Ingredient: | aspirin; caffeine; orphenadrine citrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 385MG;30MG;25MG | ||||
| Approval Date: | Nov 27, 1996 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 770MG;60MG;50MG | ||||
| Approval Date: | Nov 27, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
